| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/22/1998 | US5811447 Therapeutic inhibitor of vascular smooth muscle cells |
| 09/22/1998 | US5811446 Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| 09/22/1998 | US5811445 Angiotensin ii inhibitors |
| 09/22/1998 | US5811444 Compositions for reducing abnormal stimulation of endothelin receptors and novel compounds |
| 09/22/1998 | US5811443 Side effect reduction |
| 09/22/1998 | US5811442 Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow |
| 09/22/1998 | US5811441 Inhibition of platelet aggregation; treatment of autoimmune diseases |
| 09/22/1998 | US5811439 Antidiabetic agents; side effect reduction; antilepemic agents |
| 09/22/1998 | US5811438 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 09/22/1998 | US5811437 Treating cardiovascular disorder, gastrointestinal disorder, nervous system disorder related to reduced endothelial nitric oxide production |
| 09/22/1998 | US5811436 Complexed with amberlite irp-88; administering to treat or prevent mixed anxiety and depression |
| 09/22/1998 | US5811435 2- (4-heteroaryl-1-piperidinyl)alkyl!-1,3-dioxanes and related compounds and their therapeutic utility |
| 09/22/1998 | US5811434 Methods and compositions for stimulating neurite growth |
| 09/22/1998 | US5811433 1,6-naphthyridonecarboxylic acid derivatives |
| 09/22/1998 | US5811431 Treating or preventing pain, inflammation, migraine, emesis, postherpetic neuralgia |
| 09/22/1998 | US5811430 1 (2-pyrimidinyloxy) alkyl!-4- (heteroaryl) Piperidines and related compounds and their therapeutic utility |
| 09/22/1998 | US5811429 Bicyclic heterocyclic compounds |
| 09/22/1998 | US5811426 Urea and thiourea derivatives of azolones |
| 09/22/1998 | US5811423 Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 09/22/1998 | US5811422 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 09/22/1998 | US5811421 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 09/22/1998 | US5811420 Fungarrestins |
| 09/22/1998 | US5811419 Isooxacephem-derivatives |
| 09/22/1998 | US5811418 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 09/22/1998 | US5811417 Forming aqueous suspension of prednisolone in polyacrylic acid or polyacrylate, transforming into gel |
| 09/22/1998 | US5811416 Administering to treat disorders such as dysmenorrhea, preterm labor, preeclampsia, or fetal growth retardation; also hormone replacement therapy, hypertension |
| 09/22/1998 | US5811415 Lipophilic benzothiophenes |
| 09/22/1998 | US5811414 Topical application of mixtures containing substituted cholecalciferols |
| 09/22/1998 | US5811413 Compositions for regulating skin wrinkles and/or skin atrophy |
| 09/22/1998 | US5811412 Reducing tetracycline resistance in living cells |
| 09/22/1998 | US5811410 Nonsteroidal antiinflammatory drugs |
| 09/22/1998 | US5811409 Treatment of cholera |
| 09/22/1998 | US5811407 Using alphaviruses as vectors containing immunogenic or therapeutic proteins; |
| 09/22/1998 | US5811406 Stabilized by adding cryoprotectant and lyophilizing; delivering to cell tissue |
| 09/22/1998 | US5811405 Pharmaceuticals, diagnostic agents |
| 09/22/1998 | US5811400 Analgesics, immunosuppressive agents |
| 09/22/1998 | US5811389 Inhibiting platelet aggregation; blood disorders |
| 09/22/1998 | US5811388 Delivery of drugs to the lower GI tract |
| 09/22/1998 | US5811297 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages |
| 09/22/1998 | US5811275 HIV-specific ribozymes |
| 09/22/1998 | US5811131 Tasteless forms of basic drugs prepared by adsorption in situ |
| 09/22/1998 | US5811130 Danofloxacin, magnesium compound. zinc compound, antioxidant,co-solvent |
| 09/22/1998 | US5811128 Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor |
| 09/22/1998 | US5811127 Desferrioxamine oral delivery system |
| 09/22/1998 | US5811125 Natural laxative |
| 09/22/1998 | US5811123 Method of treating mucosal tissue |
| 09/22/1998 | US5811120 Solid orally administerable raloxifene hydrochloride pharmaceutical formulation |
| 09/22/1998 | US5811119 Formulation and use of carotenoids in treatment of cancer |
| 09/22/1998 | US5811118 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| 09/22/1998 | US5811117 Percutaneously absorbable preparation containing cohesive strength improving agent |
| 09/22/1998 | US5811111 Compositions for topical delivery of active ingredients |
| 09/22/1998 | US5811110 Applying to produce a synergistic enhancement in keratinocyte proliferation and synergistic inhibition of keratinocyte differentiation |
| 09/22/1998 | US5811107 Skin cleanser |
| 09/22/1998 | US5811097 Decreasing growth of tumor cells by administering blocking agent which binds to extracellular domain of cytotoxic t-lymphocyte-associated molecule and inhibits signaling |
| 09/22/1998 | US5811091 Polymerizable butyl 2-cyanoacrylate and polyvinylpyrrolidone iodine complex; bandages; wound dressings; surgical drapes and sutures; compatibility; releasing |
| 09/22/1998 | US5811088 Antiinfective compounds and methods of use |
| 09/22/1998 | US5811083 Treating or retarding lipid peroxidation mediated skin disorders |
| 09/22/1998 | US5811078 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions therewith |
| 09/22/1998 | US5811075 Method and agents for removing advanced glycosylation endproducts |
| 09/22/1998 | US5810018 Method, composition and apparatus for reducing the incidence of cigarette smoking |
| 09/22/1998 | CA2138367C Use of phosphonates for the treatment of osteoporosis |
| 09/22/1998 | CA2138366C Methods for the treatment of arthritis using phosphonates and nsaids |
| 09/22/1998 | CA2135603C Solid dispersion compositions of tebufelone |
| 09/22/1998 | CA2131000C Indoles |
| 09/22/1998 | CA2130665C Benzimidazole carbamites |
| 09/22/1998 | CA2125283C Medicament containing a 2-arylpropionic acid derivate as a nanosol and its preparation |
| 09/22/1998 | CA2125281C Immediate-effect ibuprofen-containing medicament and its use |
| 09/22/1998 | CA2120616C Benzimidazole anthelmintic agents |
| 09/22/1998 | CA2115279C Pharmaceutical products with a content of dexpanthenol for topical applications |
| 09/22/1998 | CA2093797C Substituted imidazobenzazepines and imidazopyridoazepines |
| 09/22/1998 | CA2093221C N-sulfonylindoline derivatives carrying an amide functional group, their preparation, and the pharmaceutical compositions in which they are present |
| 09/22/1998 | CA2086434C Quinuclidine derivatives |
| 09/22/1998 | CA2056911C Hiv protease inhibitors |
| 09/22/1998 | CA2054471C Aminoglycoside composition having substantially reduced nephrotoxicity induced by the amino glycoside |
| 09/22/1998 | CA2050679C Preparation of liposome and lipid complex compositions |
| 09/22/1998 | CA1340055C Process for the preparation of tertiary carbinols containing an aminic substituent |
| 09/21/1998 | CA2232787A1 Antiallergic agent having an anti-oxidant action |
| 09/21/1998 | CA2232637A1 Composition containing a compound which directly or indirectly modifies the activity of endogenous t1-m protein |
| 09/20/1998 | CA2232467A1 Imidazoles with serotonin receptor binding activity |
| 09/18/1998 | CA2232125A1 Therapeutic uses of finasteride |
| 09/17/1998 | WO1998040497A2 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
| 09/17/1998 | WO1998040493A1 Fiv vaccine |
| 09/17/1998 | WO1998040492A1 Compositions and methods for elimination of unwanted cells |
| 09/17/1998 | WO1998040479A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 09/17/1998 | WO1998040393A1 Novel mycaminosyltylonolide derivatives |
| 09/17/1998 | WO1998040386A1 Dioxino derivatives and their use as therapeutic agents |
| 09/17/1998 | WO1998040385A1 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE |
| 09/17/1998 | WO1998040384A1 1,5-dihydro-pyrazolo[3,4-d]-pyrimidinone derivatives |
| 09/17/1998 | WO1998040383A1 Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles |
| 09/17/1998 | WO1998040382A1 Novel tetrazoles |
| 09/17/1998 | WO1998040381A1 Inhibitors of impdh enzyme |
| 09/17/1998 | WO1998040380A1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| 09/17/1998 | WO1998040375A2 COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS |
| 09/17/1998 | WO1998040373A1 Ring opening metathesis of alkenes |
| 09/17/1998 | WO1998040370A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | WO1998040364A1 Lta4 hydrolase inhibitors |
| 09/17/1998 | WO1998040357A2 Hiv protease inhibitors |
| 09/17/1998 | WO1998040356A1 Drugs containing aminopyridine derivatives as the active ingredient |
| 09/17/1998 | WO1998040353A1 Novel heterocyclic compounds |
| 09/17/1998 | WO1998040350A1 Salicylic acid-sphingoid base derivatives and uses thereof |